Gambling, Resorts & Casinos
Compare Stocks
4 / 10Stock Comparison
SBET vs RSI vs DKNG vs GENI
Revenue, margins, valuation, and 5-year total return — side by side.
Gambling, Resorts & Casinos
Gambling, Resorts & Casinos
Internet Content & Information
SBET vs RSI vs DKNG vs GENI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Gambling, Resorts & Casinos | Gambling, Resorts & Casinos | Gambling, Resorts & Casinos | Internet Content & Information |
| Market Cap | $1.46B | $2.96B | $12.65B | $1.08B |
| Revenue (TTM) | $28M | $1.24B | $6.29B | $713M |
| Net Income (TTM) | $-735M | $37M | $59M | $-159M |
| Gross Margin | 93.2% | 34.9% | 41.8% | 22.6% |
| Operating Margin | -20.0% | 9.3% | 0.6% | -18.3% |
| Forward P/E | 6.1x | 46.3x | 104.4x | 161.2x |
| Total Debt | $0.00 | $18M | $1.93B | $30M |
| Cash & Equiv. | $29M | $341M | $1.60B | $281M |
SBET vs RSI vs DKNG vs GENI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 20 | May 26 | Return |
|---|---|---|---|
| SharpLink Gaming Lt… (SBET) | 100 | 2.7 | -97.3% |
| Rush Street Interac… (RSI) | 100 | 249.0 | +149.0% |
| DraftKings Inc. (DKNG) | 100 | 72.1 | -27.9% |
| Genius Sports Limit… (GENI) | 100 | 43.8 | -56.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SBET vs RSI vs DKNG vs GENI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SBET is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 6.7%, EPS growth 53.7%, 3Y rev CAGR 100.3%
- 6.7% revenue growth vs RSI's 22.8%
- Lower P/E (6.1x vs 104.4x)
RSI carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 1.03
- 188.4% 10Y total return vs DKNG's 160.4%
- Lower volatility, beta 1.03, Low D/E 6.1%, current ratio 1.93x
- Beta 1.03, current ratio 1.93x
DKNG plays a supporting role in this comparison — it may shine differently against other peers.
GENI lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 6.7% revenue growth vs RSI's 22.8% | |
| Value | Lower P/E (6.1x vs 104.4x) | |
| Quality / Margins | 3.0% margin vs SBET's -26.2% | |
| Stability / Safety | Beta 1.03 vs SBET's 3.41 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +135.5% vs GENI's -56.9% | |
| Efficiency (ROA) | 6.0% ROA vs SBET's -49.3% |
SBET vs RSI vs DKNG vs GENI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SBET vs RSI vs DKNG vs GENI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
RSI leads in 4 of 6 categories
SBET leads 0 • DKNG leads 0 • GENI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
RSI leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DKNG is the larger business by revenue, generating $6.3B annually — 224.3x SBET's $28M. RSI is the more profitable business, keeping 3.0% of every revenue dollar as net income compared to SBET's -26.2%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $28M | $1.2B | $6.3B | $713M |
| EBITDAEarnings before interest/tax | -$561M | $156M | $242M | -$54M |
| Net IncomeAfter-tax profit | -$735M | $37M | $59M | -$159M |
| Free Cash FlowCash after capex | -$18M | $147M | $679M | $16M |
| Gross MarginGross profit ÷ Revenue | +93.2% | +34.9% | +41.8% | +22.6% |
| Operating MarginEBIT ÷ Revenue | -20.0% | +9.3% | +0.6% | -18.3% |
| Net MarginNet income ÷ Revenue | -26.2% | +3.0% | +0.9% | -22.3% |
| FCF MarginFCF ÷ Revenue | -65.1% | +11.8% | +10.8% | +2.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +18.2% | +41.1% | +16.8% | +30.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +94.3% | +60.0% | +143.7% | -6.0% |
Valuation Metrics
Evenly matched — SBET and GENI each lead in 2 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, RSI's 20.7x EV/EBITDA is more attractive than DKNG's 50.0x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.5B | $3.0B | $12.7B | $1.1B |
| Enterprise ValueMkt cap + debt − cash | $1.4B | $2.6B | $13.0B | $834M |
| Trailing P/EPrice ÷ TTM EPS | -1.01x | 198.14x | -3150.62x | -10.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 6.10x | 46.27x | 104.42x | 161.17x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 20.74x | 49.99x | — |
| Price / SalesMarket cap ÷ Revenue | 52.16x | 2.61x | 2.09x | 1.62x |
| Price / BookPrice ÷ Book value/share | 0.60x | 21.58x | 20.04x | 1.55x |
| Price / FCFMarket cap ÷ FCF | — | 18.05x | 19.54x | 16.79x |
Profitability & Efficiency
RSI leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
RSI delivers a 12.9% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $-49 for SBET. GENI carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to DKNG's 3.06x. On the Piotroski fundamental quality scale (0–9), DKNG scores 7/9 vs GENI's 3/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -49.5% | +12.9% | +7.9% | -22.2% |
| ROA (TTM)Return on assets | -49.3% | +6.0% | +1.3% | -15.4% |
| ROICReturn on invested capital | -35.2% | — | -0.9% | -16.6% |
| ROCEReturn on capital employed | -46.3% | +26.3% | -0.6% | -15.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 7 | 3 |
| Debt / EquityFinancial leverage | — | 0.06x | 3.06x | 0.04x |
| Net DebtTotal debt minus cash | -$29M | -$322M | $330M | -$250M |
| Cash & Equiv.Liquid assets | $29M | $341M | $1.6B | $281M |
| Total DebtShort + long-term debt | $0 | $18M | $1.9B | $30M |
| Interest CoverageEBIT ÷ Interest expense | — | — | 4.25x | -75.96x |
Total Returns (Dividends Reinvested)
RSI leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in RSI five years ago would be worth $22,371 today (with dividends reinvested), compared to $117 for SBET. Over the past 12 months, RSI leads with a +135.5% total return vs GENI's -56.9%. The 3-year compound annual growth rate (CAGR) favors RSI at 105.0% vs SBET's -42.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -23.2% | +43.7% | -28.4% | -59.2% |
| 1-Year ReturnPast 12 months | +134.7% | +135.5% | -27.8% | -56.9% |
| 3-Year ReturnCumulative with dividends | -81.4% | +761.5% | +5.5% | +8.4% |
| 5-Year ReturnCumulative with dividends | -98.8% | +123.7% | -43.7% | -76.5% |
| 10-Year ReturnCumulative with dividends | -98.5% | +188.4% | +160.4% | -56.0% |
| CAGR (3Y)Annualised 3-year return | -42.9% | +105.0% | +1.8% | +2.7% |
Risk & Volatility
RSI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
RSI is the less volatile stock with a 1.03 beta — it tends to amplify market swings less than SBET's 3.41 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RSI currently trades 94.9% from its 52-week high vs SBET's 6.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.41x | 1.03x | 1.06x | 1.39x |
| 52-Week HighHighest price in past year | $124.12 | $29.24 | $48.78 | $13.73 |
| 52-Week LowLowest price in past year | $2.41 | $11.50 | $20.46 | $3.83 |
| % of 52W HighCurrent price vs 52-week peak | +6.0% | +94.9% | +52.3% | +32.0% |
| RSI (14)Momentum oscillator 0–100 | 52.9 | 69.6 | 63.3 | 54.8 |
| Avg Volume (50D)Average daily shares traded | 6.9M | 1.7M | 13.3M | 5.6M |
Analyst Outlook
Evenly matched — RSI and GENI each lead in 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: SBET as "Buy", RSI as "Buy", DKNG as "Buy", GENI as "Buy". Consensus price targets imply 153.9% upside for GENI (target: $11) vs 9.6% for RSI (target: $30).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $17.00 | $30.40 | $36.64 | $11.17 |
| # AnalystsCovering analysts | 3 | 13 | 48 | 19 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | 1 | — | 1 |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +2.2% | +0.3% | +6.6% | 0.0% |
RSI leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 2 categories are tied.
SBET vs RSI vs DKNG vs GENI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SBET or RSI or DKNG or GENI a better buy right now?
For growth investors, SharpLink Gaming Ltd.
(SBET) is the stronger pick with 666. 0% revenue growth year-over-year, versus 22. 8% for Rush Street Interactive, Inc. (RSI). Rush Street Interactive, Inc. (RSI) offers the better valuation at 198. 1x trailing P/E (46. 3x forward), making it the more compelling value choice. Analysts rate SharpLink Gaming Ltd. (SBET) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SBET or RSI or DKNG or GENI?
On forward P/E, SharpLink Gaming Ltd.
is actually cheaper at 6. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — SBET or RSI or DKNG or GENI?
Over the past 5 years, Rush Street Interactive, Inc.
(RSI) delivered a total return of +123. 7%, compared to -98. 8% for SharpLink Gaming Ltd. (SBET). Over 10 years, the gap is even starker: RSI returned +188. 4% versus SBET's -98. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SBET or RSI or DKNG or GENI?
By beta (market sensitivity over 5 years), Rush Street Interactive, Inc.
(RSI) is the lower-risk stock at 1. 03β versus SharpLink Gaming Ltd. 's 3. 41β — meaning SBET is approximately 230% more volatile than RSI relative to the S&P 500. On balance sheet safety, Genius Sports Limited (GENI) carries a lower debt/equity ratio of 4% versus 3% for DraftKings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SBET or RSI or DKNG or GENI?
By revenue growth (latest reported year), SharpLink Gaming Ltd.
(SBET) is pulling ahead at 666. 0% versus 22. 8% for Rush Street Interactive, Inc. (RSI). On earnings-per-share growth, the picture is similar: Rush Street Interactive, Inc. grew EPS 418. 5% year-over-year, compared to -63. 0% for Genius Sports Limited. Over a 3-year CAGR, SBET leads at 100. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SBET or RSI or DKNG or GENI?
Rush Street Interactive, Inc.
(RSI) is the more profitable company, earning 2. 9% net margin versus -26. 2% for SharpLink Gaming Ltd. — meaning it keeps 2. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RSI leads at 7. 7% versus -1999. 5% for SBET. At the gross margin level — before operating expenses — SBET leads at 93. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SBET or RSI or DKNG or GENI more undervalued right now?
On forward earnings alone, SharpLink Gaming Ltd.
(SBET) trades at 6. 1x forward P/E versus 161. 2x for Genius Sports Limited — 155. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GENI: 153. 9% to $11. 17.
08Which pays a better dividend — SBET or RSI or DKNG or GENI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is SBET or RSI or DKNG or GENI better for a retirement portfolio?
For long-horizon retirement investors, Rush Street Interactive, Inc.
(RSI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 03), +188. 4% 10Y return). SharpLink Gaming Ltd. (SBET) carries a higher beta of 3. 41 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (RSI: +188. 4%, SBET: -98. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SBET and RSI and DKNG and GENI?
These companies operate in different sectors (SBET (Consumer Cyclical) and RSI (Consumer Cyclical) and DKNG (Consumer Cyclical) and GENI (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 15%
- Gross Margin > 13%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.